IAPP and type 2 diabetes mellitus: Work by the same group provided the first experimental evidence of an interaction between two IDPs whose aggregation is associated with diseases in different tissues, namely, islet amyloid polypeptide (IAPP), implicated in type 2 diabetes, and a fragment of tau, implicated in Alzheimer’s (Arya et al., 2019).